metabotropic glutamate receptor 3 antagonist
Alternative Names: mGluR3 antagonistLatest Information Update: 31 Mar 2009
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Metabotropic glutamate receptor 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Migraine